DE69006000T2 - Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln. - Google Patents

Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.

Info

Publication number
DE69006000T2
DE69006000T2 DE90312217T DE69006000T DE69006000T2 DE 69006000 T2 DE69006000 T2 DE 69006000T2 DE 90312217 T DE90312217 T DE 90312217T DE 69006000 T DE69006000 T DE 69006000T DE 69006000 T2 DE69006000 T2 DE 69006000T2
Authority
DE
Germany
Prior art keywords
iontophoresis
drug delivery
topical drug
flow enhancer
transdermal flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90312217T
Other languages
English (en)
Other versions
DE69006000D1 (de
Inventor
Michael Lee Francoeur
Russell Owen Potts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69006000D1 publication Critical patent/DE69006000D1/de
Publication of DE69006000T2 publication Critical patent/DE69006000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
DE90312217T 1989-11-29 1990-11-08 Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln. Expired - Fee Related DE69006000T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/443,699 US5023085A (en) 1989-11-29 1989-11-29 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals

Publications (2)

Publication Number Publication Date
DE69006000D1 DE69006000D1 (de) 1994-02-24
DE69006000T2 true DE69006000T2 (de) 1994-05-05

Family

ID=23761854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90312217T Expired - Fee Related DE69006000T2 (de) 1989-11-29 1990-11-08 Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.

Country Status (17)

Country Link
US (1) US5023085A (de)
EP (1) EP0435436B1 (de)
JP (1) JPH0688912B2 (de)
KR (1) KR930007248B1 (de)
AT (1) ATE99961T1 (de)
AU (1) AU613281B1 (de)
CA (1) CA2030943A1 (de)
DE (1) DE69006000T2 (de)
DK (1) DK0435436T3 (de)
HU (1) HUT55629A (de)
IE (1) IE63597B1 (de)
IL (1) IL96449A (de)
MY (1) MY109727A (de)
NZ (1) NZ236253A (de)
PH (1) PH27105A (de)
PT (1) PT96021B (de)
ZA (1) ZA909512B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
WO1988006041A1 (en) * 1987-02-23 1988-08-25 Shiseido Company Ltd. Percutaneous absorption promoter and dermatologic preparation for external use
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5334138A (en) * 1990-03-15 1994-08-02 North Carolina State University Method and composition for increased skin concentration of active agents by iontophoresis
US5383848A (en) * 1990-04-12 1995-01-24 Gensia, Inc. Iontophoretic administration of drugs
US6238381B1 (en) 1990-11-01 2001-05-29 Robert Tapper Iontophoretic treatment system
US6582416B2 (en) 1990-11-01 2003-06-24 Robert Tapper Iontophoretic treatment system
US6600950B1 (en) * 1990-11-01 2003-07-29 Robert Tapper Iontophoretic treatment system
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US6139537A (en) * 1990-11-01 2000-10-31 Tapper; Robert Iontophoretic treatment system
US6235013B1 (en) 1990-11-01 2001-05-22 Robert Tapper Iontophoretic treatment system
US6223076B1 (en) 1990-11-01 2001-04-24 Robert Tapper Sweat control system
US6575957B1 (en) * 1990-11-01 2003-06-10 Robert Tapper Iontophoretic treatment system
US5131403A (en) * 1991-06-05 1992-07-21 Becton Dickinson And Company Method for obtaining blood using iontophoresis
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
ATE169826T1 (de) * 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
CA2183875C (en) * 1992-06-02 2003-10-14 Robert M. Myers Electrotransport drug delivery device
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
ES2153485T3 (es) * 1994-07-13 2001-03-01 Alza Corp Composicion y procedimiento que incrementa la difusion percutanea por electrotransporte de una substancia.
US5540654A (en) * 1994-09-02 1996-07-30 North Carolina State University Iontophoretic electrode
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6355025B1 (en) 1995-06-07 2002-03-12 Alza Corporation Adjustable electrotransport drug delivery using a fixed output controller
AU7286996A (en) * 1995-10-18 1997-05-07 Ciba-Geigy Ag Thermopile powered transdermal drug delivery device
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
AUPO907697A0 (en) * 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
EP1135188B1 (de) 1998-11-02 2007-11-28 ALZA Corporation Iontophoretische vorrichtung mit einem materialverträglichen antimikrobiellen wirkstoff
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
CA2400325A1 (en) 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for delivering agents using alternating current
WO2001060448A1 (en) 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for extracting substances using alternating current
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
MXPA03009121A (es) * 2001-04-04 2004-11-22 Johnson & Johnson Dispositivo de suministro de electrotransporte transdermico que incluye una composicion de reserva compatible antimicrobiana.
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
EP1898922A4 (de) * 2005-07-04 2012-03-14 Ramu Krishnan Verbessertes arzneimittel oder pharmazeutische verbindungen und eine zubereitung davon
WO2007147043A2 (en) * 2006-06-16 2007-12-21 Transport Pharmaceutical, Inc. Pharmaceutical formulations for iontophoretic tetracycline antibiotic delivery
WO2009158477A1 (en) 2008-06-25 2009-12-30 Us Worldmeds Llc Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery
US20110281834A1 (en) * 2008-11-10 2011-11-17 Friden Phillip M Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid
WO2011002776A1 (en) * 2009-06-29 2011-01-06 Nitric Biotherapeutics, Inc. Pharmaceutical formulations for iontophoretic delivery of an immunomodulator
CA2796575C (en) 2010-04-13 2018-05-15 Relmada Therapeutics, Inc. Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
MX2021011641A (es) 2013-12-24 2023-03-10 Durect Corp Usos de sulfatos de colesterol oxigenados (soc).
US11564970B2 (en) 2017-10-09 2023-01-31 The Broad Institute, Inc. Compositions and methods for combinatorial drug discovery in nanoliter droplets

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS6036299B2 (ja) * 1981-07-02 1985-08-20 タカラベルモント株式会社 イオン導入器
HU185691B (en) * 1982-02-09 1985-03-28 Richter Gedeon Vegyeszet Process for preparing a new analgetic pharmaceutical composition
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4919648A (en) * 1983-08-18 1990-04-24 Drug Delivery Systems Inc. High tack drug patch
JPS6222662A (ja) * 1985-07-19 1987-01-30 林原　健 イオン導入電子治療器
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
PT89837B (pt) * 1988-02-29 1994-01-31 Pfizer Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina

Also Published As

Publication number Publication date
KR910009250A (ko) 1991-06-28
DK0435436T3 (da) 1994-02-28
NZ236253A (en) 1993-05-26
KR930007248B1 (ko) 1993-08-04
AU613281B1 (en) 1991-07-25
ATE99961T1 (de) 1994-01-15
PT96021B (pt) 1998-02-27
IE63597B1 (en) 1995-05-17
JPH03176426A (ja) 1991-07-31
PT96021A (pt) 1991-09-13
IE904281A1 (en) 1991-06-05
CA2030943A1 (en) 1991-05-30
EP0435436A3 (en) 1992-01-08
HUT55629A (en) 1991-06-28
EP0435436A2 (de) 1991-07-03
JPH0688912B2 (ja) 1994-11-09
MY109727A (en) 1997-05-31
ZA909512B (en) 1992-06-24
DE69006000D1 (de) 1994-02-24
PH27105A (en) 1993-03-16
IL96449A (en) 1996-07-23
EP0435436B1 (de) 1994-01-12
US5023085A (en) 1991-06-11

Similar Documents

Publication Publication Date Title
DE69006000D1 (de) Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.
DE69401945D1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
ATE67417T1 (de) Medizinische einrichtung zur pulsatilen transdermalen verabreichung von biologisch aktiven wirkstoffen.
ATE214946T1 (de) Zusammensetzungen zur penetrationsförderung in der haut durch gebrauch von acryllactylaten
DK407587A (da) Transdermalt indgivelsessystem
DE68910867T2 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
ATE63813T1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
DE3587794D1 (de) Pharmazeutische Präparate.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3877630D1 (de) Transkutane verabreichung von pharmazeutika.
DE3862017D1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
GR3004113T3 (de)
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
FR2426460A1 (fr) Composition antiallergique
FR2579463B1 (fr) Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
AP8500009A0 (en) New phenoxypropanolamine salts and pharmaceutical preparations thereof.
ATE94197T1 (de) Eindringungserhoehende mittel zur transdermalen verabreichung systemischer mittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee